U.S. Markets open in 13 mins

Pfizer’s Announces It Will Defer Company’s Price Increases

Market Watch

Following an extensive discussion with President Trump today, Pfizer’s Chairman and CEO Ian Read announced that it will defer the company’s price increases that were effective on July 1 to give the president an opportunity to work on his blueprint to strengthen the healthcare system and provide more access for patients. The company will return these prices to their pre-July 1 levels as soon as technically possible, and the prices will remain in effect until the earlier of when the president’s blueprint goes into effect or the end of the year – whichever is sooner. “Pfizer shares the President’s concern for patients and commitment to providing affordable access to the medicines they need,” said Ian Read.